Reflections on the EAU Annual Congress

Charnow, Jody A.
April 2013
Renal & Urology News;Apr2013, Vol. 12 Issue 4, p6
The author offers views about the European Association of Urology Annual Conference which presented several studies of the treatment of localized prostate cancer (PCa).


Related Articles

  • Focal Therapy for Prostate Cancer. Emberton, Mark; Konijeti, Ramdev; Kibel, Adam S. // AUANews;Sep2012, Vol. 17 Issue 9, p19 

    The article presents a debate about focal therapy for prostate cancer. A physician says focal therapy should be seen as a legitimate, necessary response to a changing diagnostic and therapeutic pathway for prostate cancer. However, two physicians noted that the multifocal nature of prostate...

  • Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. Langsenlehner, Tanja; Thurner, Eva-Maria; Krenn-Pilko, Sabine; Langsenlehner, Uwe; Stojakovic, Tatjana; Gerger, Armin; Pichler, Martin // World Journal of Urology;Nov2015, Vol. 33 Issue 11, p1661 

    Purpose: Recent studies have expanded the concept that the systemic inflammatory response has an important role in the progression of several solid tumors. The neutrophil-to-lymphocyte ratio (NLR), an easily determinable marker of systemic inflammation, has been associated with clinical outcome...

  • Doing it the Bristol way. Graham, Sarah; Humphrey, Pauline; Hilton, Sue // Synergy: Imaging & Therapy Practice;Aug2009, p22 

    The article focuses on the use of high dose rate (HDR) brachytherapy for the treatment of prostate cancer developed at Bristol Haematology and Oncology Center in Great Britain. It details the procedure for the brachytherapy stressing its involvement of a number of thin hollow catheters into the...

  • High-Dose Brachytherapy For Treating Prostate Cancer: Nursing Considerations. Colella, Joan; Scrofine, Suzanna // Urologic Nursing;Feb2004, Vol. 24 Issue 1, p39 

    Explains nursing factors to consider when applying high-dose brachytherapy in treating prostate cancer. Description of the treatment; Discussion of appropriate nursing care in various stages of implantation; Post-operative and post-implant care.

  • PROSTATE CANCER. Perry, Margaret // Practice Nurse;6/13/2003, Vol. 25 Issue 11, p62 

    Focuses on the screening and treatment options for men with possible prostate cancer. Symptoms of prostate cancer; Risk factors of prostate cancer; Screening options for the disease; Treatment; Advice to men regarding cancer. INSET: EARLY STAGE CANCER.

  • Pilot study shows combination therapy containing Quadramet impacts prostate specific antigen levels.  // PharmaWatch: Cancer;August 2003, Vol. 2 Issue 8, p24 

    Presents the results of a pilot study showing that combination therapy containing Quaramet and Taxotere increases prostate specific antigen levels. Preliminary data showing that the combination is simple and efficient.

  • Praecis makes first European regulatory submission for Plenaxis.  // PharmaWatch: Cancer;August 2003, Vol. 2 Issue 8, p25 

    Reports that Praecis Pharmaceuticals has begun the European regulatory process for its Plenaxis product in treating prostate cancer. Marketing Authorization Application process.

  • Manpower and Training are the Focus of the Society of University Urologists in 2013. Carson, Culley C. // AUANews;Apr2013, Vol. 18 Issue 4, p31 

    The article presents several topics about manpower which are to be discussed at the Society of University Urologists (SUU) meeting to be convened in San Diego, California on May 3, 2013.

  • Challenges From Every Angle Addressed at Upcoming Society of University Urologists Annual Meeting. Terris, Martha K. // AUANews;Feb2012, Vol. 17 Issue 2, p10 

    The article offers information on the Society of University Urologists (SUU) Annual Meeting to be held at Omni Hotel in Atlanta, Georgia on May 18, 2012.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics